Tag: The Lancet

VAPOUR trial produces robust new evidence for vertebroplasty

The VAPOUR trial proves that vertebroplasty is effective in patients with severe pain and fractures of less than six weeks’ duration, when an adequate...

Vertebroplasty trumps placebo in treatment of painful spinal fractures

On 17 August, a multicentre, randomised, double-blind, placebo-controlled trial—the VAPOUR trial—was published online ahead of print in The Lancet. Six-month data from the trial...